Try it
Biochemistry · Clinical biochemistry: NT-proBNP with sacubitril
Sample itemA man with chronic heart failure is switched from valsartan to sacubitril-valsartan. His BNP rises after the change though he feels better. Which biomarker is preferred for monitoring him, and why?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. NT-proBNP, because neprilysin does not degrade it
Neprilysin degrades BNP, so inhibiting it raises BNP levels independent of the clinical state. NT-proBNP, the inactive fragment cleaved from proBNP, is not a neprilysin substrate and remains a valid marker of wall stress. BNP and NT-proBNP are both released from ventricular myocytes in response to stretch.
Option by option
A. NT-proBNP, because neprilysin does not degrade it (correct)
Correct. NT-proBNP is not cleared by neprilysin and so is unaffected by the drug.
B. Troponin T, because it falls with neprilysin inhibition
Troponin T reflects myocyte injury and is not a measure of wall stress in heart failure.
C. Procalcitonin, because it reflects ventricular wall stress
Procalcitonin is a marker of bacterial infection and not of ventricular wall stress.
D. BNP, because neprilysin degrades it faster on the drug
Neprilysin inhibition slows BNP degradation, so BNP rises falsely and is a poor marker here.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Biochemistry questions
- Nucleotide metabolismA 4-year-old boy has intellectual disability, dystonia, self-mutilation and hyperuricaem…
- VitaminsA patient with megaloblastic anaemia and mild neurological signs has raised serum methyl…
- Amino acid metabolismA baby has a mousy odour, fair skin and developmental delay. Which enzyme is deficient?
- Glycogen storage diseasesA child has severe fasting hypoglycaemia, hepatomegaly, lactic acidosis and hyperuricaem…